Long-term Effects ReSet Your Mind - Mechanisms

October 9, 2023 updated by: Philipps University Marburg Medical Center

Long-term Effects of an Online Intervention Targeting Depression and Reward Sensitivity - Predictors and Mechanisms of Treatment Success

See: ClinicalTrials.gov ID: NCT05402150

Relevant for this Paper:

This investigation aims to evaluate the stability of the effectiveness of different two-week online interventions in a four months follow-up regarding reward sensitivity, anhedonia and depression.

The authors will further investigate factors influencing treatment success regarding reward sensitivity. The investigators assume that the more depressive expectations and stress improve during our online intervention, the more change in reward insensitivity is experienced at follow-up. In addition, it is hypothesized that the more people engaged in physical activities and social encounters during the two-week online intervention, the more change in reward insensitivity is experienced at follow-up.

Study Overview

Detailed Description

See for main study: ClinicalTrials.gov ID: NCT05402150.

A possible maintaining role in depressive symptoms plays reward hyposensitivity. Therefore, treatments should include evidence-based psychological interventions that target and modify reward insensitivity. Prior research lacks studies investigating reward sensitivity as main outcome measure, especially in the web-based format. This is why this study investigated an online intervention with the following groups regarding effectively increasing reward sensitivity compared to a waitlist control condition:

a) mindfulness-based interventions, b) behavioral activation, c) a combination of both.

The daily exercises were supported via videos and worksheets. Here, the investigators explore the effects after a four-months follow-up. In addition, this paper will deal with the long-term prediction of reward sensitivity, a feature not considered in our main paper preregistered with the ID NCT05402150. Factors, which are considered to play a big role in reward sensitivity are perceived stress, depressive expectations, physical activity and the frequency of social encounters.

Study Type

Interventional

Enrollment (Actual)

224

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Marburg, Germany, 35037
        • Philipps University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18 or above
  • Fluent in German
  • Informed consent
  • Depressive symptoms (PHQ-9 > 5)

Exclusion Criteria:

  • suicidality, severe depression
  • current or lifetime: substance use disorder, psychotic disorders, bipolar I or II
  • current psychotherapy
  • if antidepressant medication: has not been stable over the last 4 weeks

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Behavioral Activation
14 days of daily excercises
- instruction to create a list of individual positive activities. - instruction to include daily positive activities and fill out a mood protocol, which covers the time period shortly before, during and after the activity.
Experimental: Mindfulness and Gratitude
14 days of daily excercises
- instruction to fill out a mindfulness diary: reflection of daily pleasant situation, instructing the participants to revisit the impressions of their 5 senses during this situation, in addition they should specify how long they have actually dealt with
Experimental: Combination: Behavioral Activation and Mindfulness and Gratitude
14 days of daily excercises
This group will do a combination of the two intervention types.
No Intervention: Waitlist control group
Will receive the intervention (combination) after two weeks of intervention time of the other groups.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Depressive symptoms (Patient Health Questionnaire-9, PHQ-9)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from 0 to 3 (0 = not at all; 1 = several days; 2 = more than a week; 3 = nearly every day).
  • PHQ-9 total score ranges from 0 to 27 (classification of scores: 5-9 mild depression; 10-14 as moderate depression; 15-19: moderately severe depression; 20 - 27 severe depression).
  • Consequently, a higher score means worse depressive symptoms.
baseline, post intervention (after 2 weeks), 4 months follow-up
Reward sensitivity (Positive Valence System Scale-21, PVSS-21)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from 1 to 9 (1 = extremely untrue of me, 2 = very untrue of me, 3 = moderately untrue of me, 4 = slightly untrue of me, 5 = neutral, 6 = slightly true of me, 7 = moderately true of me, 8 = very true of me, 9 = extremely true of me).
  • PVSS-21 total score ranges from 21 to 189.
  • Consequently, a higher score means a higher reward responding.
baseline, post intervention (after 2 weeks), 4 months follow-up
Anhedonia (Snaith-Hamilton-Pleasure-Scale, SHAPS-D)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from "Definitely Agree", "Agree", "Disagree", and "Strongly Disagree". Either of the "Disagree responses" receive a score of 1 and either of the "Agree responses" receive a score of 0.
  • SHAPS-D total score ranges from 0 to 14.
  • Consequently, a higher score means a greater state anhedonia.
baseline, post intervention (after 2 weeks), 4 months follow-up
Change in Stress level (Perceived-Stress-Scale 10, PSS-10)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from 1 to 5 (1= never, 2 = almost never, 3 = sometimes, 4 = fairly often, 5 = very often) Items 4, 5, 7 and 8 are reverse scored for the total score.
  • PH=perceived helplessness subscale; PSE=perceived self-efficacy subscale
  • PH subscale is computed by summing up Items 1, 2, 3, 6, 9 and 10; the PSE subscale is computed by summing up items 4, 5, 7 and 8
  • PSS-10 total score is the sum of all PH and reversed PSE items
  • Consequently, a higher score means a greater level of stress.
baseline, post intervention (after 2 weeks), 4 months follow-up
Change in Depressive Expectations (Depressive Expectations Scale, DES)
Time Frame: baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from 1 to 5 (1 = I disagree , 2 = I partially disagree, 3 = neutral, 4 = I partially agree, 5 = I agree).
  • DES total score ranges from 25 to 125
  • Consequently, a higher score means more dysfunctional depressive expectations.
baseline, post intervention (after 2 weeks), 4 months follow-up
Amount of physical activity reported during intervention exercises
Time Frame: during intervention
- Type of activities and reflected pleasant situations that have been selected in the daily online surveys
during intervention
Amount of social encounters reported during intervention exercises
Time Frame: during intervention
- Type of activities and reflected pleasant situations that have been selected in the daily online surveys
during intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Personality traits (Big Five Inventory 10, BFI-10)
Time Frame: Baseline, post intervention (after 2 weeks), four months follow-up]
  • Items range from 1 (disagree strongly) to 5 (agree strongly).
  • Scales: openness to experience, conscientiousness, extraversion, agreeableness and neuroticism
Baseline, post intervention (after 2 weeks), four months follow-up]
Adherence
Time Frame: post intervention (after 2 weeks), 4 months follow-up
  • Number of completed online surveys regarding the intervention exercises (T1 to T14: daily online surveys over the course of two weeks)
  • Self report of implementation of daily exercises in post intervention survey and follow up survey.
post intervention (after 2 weeks), 4 months follow-up
Treatment expectation (Generic Rating for Treatment Pre-Experiences, Treatment Expectations, and Treatment Effects, G-EEE)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow-up
- Items range from 0 to 10 (depending on the item from "no improvement" to "greatest improvement imaginable", from "no worsening" to "greatest worsening imaginable", from "no complaints" to "greatest complaints imaginable") and one item, where previous treatment experience is assessed via a choice of "I have never experienced this treatment." (continue with question 8), "I have experienced this treatment during the last 12 months (nearly) daily.", "I have experienced this treatment during the last 12 months on more than 10 days.", "I have experienced this treatment during the last 12 months on about 5 to 10 days.", I have experienced this treatment during the last 12 months on about 1 to 4 days." And "I have not experienced this treatment during the last 12 months, but I have experienced it before."
Baseline, post intervention (after 2 weeks), 4 months follow-up
Treatment credibility and expectancy (Credibility/Expectancy Questionnaire, CEQ)
Time Frame: Baseline
  • Items range from 1 to 9 (Item 1 of Set 1: 1= not at all logical, 5 = somewhat logical, 9 = very logical, Item 2 of Set

    1: 1= not at all useful, 5 = somewhat useful, 9 = very useful, Item 3 of Set 1: 1 = not at all confident, 5 = somewhat confident, 9 = very confident, Item 1 of Set 2: 1 = not at all, 5 = somewhat, 9 = very much), Item 4 of Set 1 and Item 2 of Set 2 give a choice of 0% to 100% in steps of 10 %.

  • CEQ composite score can be derived for each factor (expectancy and credibility)
Baseline
Trait reward responsiveness (Reward Responsiveness Scale, RRS)
Time Frame: Baseline, post intervention (after 2 weeks), 4 months follow-up
  • Items range from 1 to 4 (1= strong disagreement, 2 = mild disagreement, 3 = mild agreement, 4 = strong agreement)
  • RRS total score ranges from 8 to 32.
  • Consequently, a higher score means a higher reward responsiveness.
Baseline, post intervention (after 2 weeks), 4 months follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sociodemographic variables
Time Frame: baseline
- Gender, age, education, employment, medication, self report lifetime diagnosis of psychiatric conditions, previous experience with psychotherapy etc.
baseline
Perceived system usability (System usability Scale, SUS), general feedback about the online intervention
Time Frame: post intervention (after 2 weeks)
  • Items of the SUS range from 1 to 5 (1= strongly disagree to 5 = strongly agree).
  • After a computation, the SUS score can range from 0 to 100. A SUS score above a 68 is considered above average.
  • general feedback about the online intervention: free text entries about the online intervention: criticism, change requests, praise, one closed question: "Would you recommend the online intervention to someone else?" Yes/No
post intervention (after 2 weeks)
Problems and obstacles during the intervention
Time Frame: post intervention (after 2 weeks)
- Frequency of telephone contacts made with the principal contact person (Laura Potsch) and specified problems with the implementation of the daily excercises in the daily online survey
post intervention (after 2 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Winfried Rief, Prof. Dr., Dept. of Clinical Psychology and Psychotherapy, Philipps-University Marburg, Germany

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2022

Primary Completion (Actual)

May 15, 2023

Study Completion (Actual)

September 15, 2023

Study Registration Dates

First Submitted

October 2, 2023

First Submitted That Met QC Criteria

October 2, 2023

First Posted (Actual)

October 10, 2023

Study Record Updates

Last Update Posted (Actual)

October 12, 2023

Last Update Submitted That Met QC Criteria

October 9, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression Moderate

Clinical Trials on Combination of Behavioral Activation and Mindfulness and Gratitude

Subscribe